Cargando…
Infliximab for the treatment of refractory scleritis
BACKGROUND: Scleritis is a potentially blinding inflammatory disorder. Standard care consists of systemic corticosteroids and immunosuppresants. The authors describe a series of 10 patients suffering from scleritis treated with the TNF inhibitor infliximab because this scleritis was refractory to st...
Autores principales: | Doctor, Priyanka, Sultan, Amyna, Syed, Sana, Christen, William, Bhat, Pooja, Foster, C Stephen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976470/ https://www.ncbi.nlm.nih.gov/pubmed/19955205 http://dx.doi.org/10.1136/bjo.2008.150961 |
Ejemplares similares
-
Combined Infliximab and Rituximab in Necrotising Scleritis
por: Morarji, Jiten, et al.
Publicado: (2012) -
Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018) -
Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review
por: Valdes, Lianna, et al.
Publicado: (2022) -
Case series: rituximab in the treatment of refractory sight-threatening scleritis
por: van Bilsen, Kiki, et al.
Publicado: (2011) -
High Dose Infliximab in the Treatment of Refractory Uveitis: Does Dose Matter?
por: Sukumaran, Sukesh, et al.
Publicado: (2012)